Pharmacokinetic Drug-Drug Interaction Between Bisoprolol and Ivabradine in Healthy Volunteers
NCT03485482 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2018-04-02
Summary
The purpose of the study was to investigate the potential interaction between ivabradine and bisoprolol in healthy subjects.
Conditions
Interventions
- DRUG
-
Bisoprolol
bisoprolo 5 mg tablets
- DRUG
-
Ivabradine
Ivabradine 10 mg tablet
- DRUG
-
combination of Ivabradine and bisoprolol
combination of 10 mg ivabradine and 5 mg bisoprolol
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Sara Shaheen, Ass. Prof · Faculty of pharamacy, Ain Shams University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2018-03-23
- Completion
- 2018-03-23
Countries
- Egypt
Study Locations
More Related Trials
-
Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia
NCT01657136 ·Status: COMPLETED ·Phase: PHASE3
-
Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome
NCT06305195 ·Status: RECRUITING
-
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
NCT07268170 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease
NCT02681978 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol
NCT01939509 ·Status: COMPLETED ·Phase: PHASE4
-
Echocardiographic Study of a Single Dose Bisoprolol Versus Nebivolol in Healthy Subjects
NCT04432610 ·Status: WITHDRAWN ·Phase: PHASE4
-
Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock
NCT06742164 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease
NCT01768585 ·Status: UNKNOWN ·Phase: PHASE4
-
To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable,Symptomatic Chronic Angina
NCT02623569 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
NCT01284868 ·Status: COMPLETED ·Phase: PHASE1
-
Ivabradine in Cirrhotic Cardiomyopathy
NCT04111133 ·Status: RECRUITING ·Phase: NA
-
Arrhythmias, Microalbuminuria and Corticosteroids
NCT03453931 ·Status: COMPLETED
-
Heart Rate Reducing Therapy in Cardiac CT Using Ivabradine and Bisoprolol
NCT02764970 ·Status: COMPLETED
-
Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris
NCT00202566 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
NCT01022463 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Genetic Polymorphisms on Response to Beta Blocker Therapy in Egyptian Patients
NCT04900545 ·Status: COMPLETED
-
Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
NCT06808321 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
NCT03278509 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure
NCT07029906 ·Status: RECRUITING ·Phase: NA
-
Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease
NCT01039389 ·Status: COMPLETED ·Phase: NA
-
The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
NCT05332457 ·Status: RECRUITING ·Phase: NA
-
Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation
NCT00348101 ·Status: COMPLETED ·Phase: PHASE3
-
Dobutamine on the Cardiac Conduction System
NCT04249258 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Beta-blockers in i-PAH
NCT01246037 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Real World Assessment of Effects of Beta-blockers on Patients With Acute Coronary Syndrome
NCT03669991 ·Status: UNKNOWN